LYKALABSNSELyka Labs Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 7 Apr · 13:21 IST

Lyka Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.5%1-day move
₹54.45
prior close
₹61.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.4-1.1-1.8-3.4+7.5+6.7+6.6+6.4+4.5+10.1+10.2+14.6+16.8+28.7
Up moveDown movePending
AI summary

Lyka Labs Limited has submitted a routine compliance certificate for Q4 FY 2025-26 (January-March 2026) as mandated by SEBI regulations. The certificate from their Registrar and Transfer Agent, MUFG Intime India Private Limited, confirms that all physical securities received for dematerialization during the quarter were properly processed and accepted/rejected to the depositories. The physical share certificates have been mutilated and cancelled, with depositories substituted as registered owners in the company's register of members within prescribed timelines.

Likely market impact

This is a standard administrative compliance filing with no direct impact on shareholders or stock performance. It merely confirms proper processing of share dematerialization requests for the quarter.